Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abecma
Pharma
FDA revisits CAR-T boxed warning on secondary cancers: Marks
“We are in the process ... of reevaluating the need for the current labeling on these products,” Peter Marks, M.D., Ph.D., said of the warnings.
Angus Liu
Nov 1, 2024 10:30am
J&J, Legend's Carvykti shows 45% survival benefit in myeloma
Sep 30, 2024 9:50am
BMS, 2seventy scrap Abecma trial in first-line multiple myeloma
Sep 25, 2024 10:52am
Bristol Myers’ top challenges, as seen by analysts
Jul 12, 2024 12:00pm
BMS leans on long-term growth drivers to dodge IRA impacts
Apr 25, 2024 12:57pm
BMS signs $380M deal with cell therapy manufacturer Cellares
Apr 22, 2024 11:10am
